Ftse Mib
34.664,36
-0,28%
DAX
18.677,87
-0,45%
S&P 500
5.307,63
0,05%
NASDAQ
0,00
0,00%
Bitcoin
67.771,30
-2,34%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cellect Biotechnology Ltd (APOP) Cellect Biotechnology Ltd (APOP) Notizie

APOP

Cellect Biotechnology (APOP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APOP
DataOraFonteTitoloSimboloCompagnia
28/06/202321:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/06/202321:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
09/05/202321:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APOPCellect Biotechnology Ltd
20/03/202311:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
15/03/202319:40Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:APOPCellect Biotechnology Ltd
03/03/202322:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APOPCellect Biotechnology Ltd
23/02/202312:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:APOPCellect Biotechnology Ltd
14/02/202320:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
09/02/202312:05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:APOPCellect Biotechnology Ltd
03/02/202312:03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202315:48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202217:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
31/08/202213:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:APOPCellect Biotechnology Ltd
04/08/202217:45Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:APOPCellect Biotechnology Ltd
03/08/202212:04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:APOPCellect Biotechnology Ltd
30/06/202222:58Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APOPCellect Biotechnology Ltd
14/06/202223:16Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:APOPCellect Biotechnology Ltd
14/04/202212:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:APOPCellect Biotechnology Ltd
15/10/202122:01GlobeNewswire Inc.Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
27/09/202115:10GlobeNewswire Inc.Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
02/09/202122:20GlobeNewswire Inc.Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.NASDAQ:APOPCellect Biotechnology Ltd
24/08/202122:16GlobeNewswire Inc.Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating ResultsNASDAQ:APOPCellect Biotechnology Ltd
13/08/202122:20GlobeNewswire Inc.The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
03/08/202122:29Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:APOPCellect Biotechnology Ltd
17/06/202100:58GlobeNewswire Inc.Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmace...NASDAQ:APOPCellect Biotechnology Ltd
19/04/202114:00GlobeNewswire Inc.Cellect Biotechnology Reports Top Line Data from Phase 1/2 Clinical TrialNASDAQ:APOPCellect Biotechnology Ltd
29/03/202115:29GlobeNewswire Inc.Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating ResultsNASDAQ:APOPCellect Biotechnology Ltd
24/03/202122:26GlobeNewswire Inc.Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic MergerNASDAQ:APOPCellect Biotechnology Ltd
11/02/202117:52Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:APOPCellect Biotechnology Ltd
20/11/202014:00GlobeNewswire Inc.Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelera...NASDAQ:APOPCellect Biotechnology Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APOP

La tua Cronologia

NASDAQ
FOZHRX
Global Commodities Compa...
USOTC
MAWAF
Maruwa (PK)
BINA
DATAETH
NYSE
LGVW.U
Longview Acquisition
TSX
TRX
TRX Gold
USOTC
MSYMF
Medical System Network (PK)
EU
S639S
S639S
COIN
XCREEUR
BOV
TEXA34M
Texas Inc DRN
COIN
VASHBTC
GATE
RENBTCBTC
renBTC
BIT
F07334
Vontobel Financial Produ...
NASDAQ
AAXYEXX
Goldman Sachs Bank Usa A...
EU
M625S
M625S
USOTC
MYCX
MYCELX Technologies (GM)
TIDE
ENGTETH
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network